SCHEMBL5301790

SCHEMBL5301790

CC(=O)Nc1c(I)c(C(=O)Cl)c(I)c(C(=O)Cl)c1I

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.58
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 2/20 0.30
GAA P10253 1/20 0.30
PKM P14618 1/20 0.30
ALOX15 P16050 1/20 0.30
HTT P42858 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
NAPRT Q6XQN6 1/20 0.30
MAPT P10636 1/20 0.30
TSHR P16473 1/20 0.30
KDM4E B2RXH2 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C9 P11712 1/20 0.30
IDO1 P14902 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3082732 0.96 LMNA (0.63) LMNASMN1; SMN2MEN1KMT2AHSD17B10
SCHEMBL11346904 0.89 LMNA (0.49) LMNASMN1; SMN2
SCHEMBL22681066 0.88 LMNA (0.50) LMNASMN1; SMN2HSD17B10L3MBTL1
SCHEMBL4919661 0.87 LMNA (0.50) LMNASMN1; SMN2
SCHEMBL8492192 0.84 LMNA (0.51) LMNASMN1; SMN2KMT2AGAAPKM
SCHEMBL8492195 0.82 LMNA (0.53) LMNASMN1; SMN2
SCHEMBL22661238 0.81 LMNA (0.47) LMNASMN1; SMN2
SCHEMBL8752140 0.81 LMNA (0.67) LMNASMN1; SMN2MEN1KMT2AHSD17B10
SCHEMBL11527929 0.81 LMNA (0.47) LMNASMN1; SMN2HTTTSHR
SCHEMBL11527932 0.81 LMNA (0.47) LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116332787-B Preparation method of contrast agent intermediate acetyl iodide 安庆朗坤药业有限公司 2023-10-27 CN claimed
CN-116332787-A Preparation method of contrast agent intermediate acetyl iodide 安庆朗坤药业有限公司 2023-06-27 CN claimed
EP-0105752-B1 X-RAY CONTRAST AGENTS NYEGAARD & CO. A/S (NO) 1986-05-07 EP claimed
EP-0105752-A1 X-ray contrast agents NYEGAARD & CO. A/S (NO) 1984-04-18 EP claimed
CN-116496171-B Synthesis of iohexol 上海慧聚药业有限公司 2025-01-10 CN disclosed
EP-4452931-A1 PROCESS FOR THE PREPARATION OF 2,4,6-TRIIODOISOPHTHALIC BISAMIDES Bracco Imaging SPA (IT) 2024-10-30 EP disclosed
CN-118414325-A Process for preparing 2,4, 6-triiodo isophthalic acid diamide 伯拉考成像股份公司 2024-07-30 CN disclosed
CN-118239857-A Preparation method of iodixanol impurity I 浙江海洲制药股份有限公司 2024-06-25 CN disclosed
CN-116332787-B Preparation method of contrast agent intermediate acetyl iodide 安庆朗坤药业有限公司 2023-10-27 CN disclosed
CN-116332787-B Preparation method of contrast agent intermediate acetyl iodide 安庆朗坤药业有限公司 2023-10-27 CN disclosed
CN-116496171-A Synthesis of iohexol 上海慧聚药业有限公司 2023-07-28 CN disclosed
WO-2023117667-A1 PROCESS FOR THE PREPARATION OF 2,4,6-TRIIODOISOPHTHALIC BISAMIDES BRACCO IMAGING SPA (IT) 2023-06-29 WO disclosed
US-4570007-A 2-Amino-1-(1,2-dioxolan-4-yl)ethanol compounds, their preparation and use SHERING AKTIENGESELLSCHAFT (DE) 1986-02-11 US disclosed
US-4547357-A OPACIFIER FOR X-RAY DIAGNOSIS SCHERING, AKTIENGESELLSCHAFT (DE) 1985-10-15 US disclosed
EP-0108638-A1 X-ray contrast agents NYEGAARD & CO. A/S (NO) 1984-05-16 EP disclosed
EP-0105752-A1 X-ray contrast agents NYEGAARD & CO. A/S (NO) 1984-04-18 EP disclosed
US-4364921-A RADIOPACITY SCHERING, AKTIENGESELLSCHAFT (DE) 1982-12-21 US disclosed
US-4307072-A X-RAY CONTRAST AGENTS MALLINCKRODT, INC. (US) 1981-12-22 US disclosed
US-4250113-A 5-SUBSTITUTED N-2,4,6-TRIIODO-N,N'-BIS-(2,3-DIHYDROXYPROPYL) ISOPHTHALAMIDE NYEGAARD & CO. A/S (NO) 1981-02-10 US disclosed
US-4107286-A Polyiods benzene derivatives and X-ray contrast media containing the same GUERBET S.A. (FR) 1978-08-15 US disclosed